Paper41379258
Association of thymoquinone-induced changes in PINK1, DRP1, TFEB, and cytochrome c expression with mitochondrial dynamics and apoptosis in HepG2 and HDF cells.
Emrah B and 1 other. Med Oncol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Association of thymoquinone-induced changes in PINK1, DRP1, TFEB, and cytochrome c expression with mitochondrial dynamics and apoptosis in HepG2 and HDF cells. Papers, record 41379258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379258
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of thymoquinone-induced changes in PINK1, DRP1, TFEB, and cytochrome c expression with mitochondrial dynamics and apoptosis in HepG2 and HDF cells.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Mitochondrial Dynamics | Major topic |
| Benzoquinones | Major topic |
| Dynamins | Major topic |
| Protein Kinases | Major topic |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | Major topic |
| Fibroblasts | Major topic |
| Cytochromes c | Major topic |
| Mitochondrial Proteins | Major topic |
| Humans | |
| Hep G2 Cells | |
| Carcinoma, Hepatocellular | |
| Liver Neoplasms | |
| Membrane Potential, Mitochondrial | |
| Mitochondria | |
| Cell Survival | |
| Cell Movement | |
| Mitophagy | |
| PTEN-Induced Putative Kinase |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1059B142200174 | The Scientific and Technological Research Council of Turkey (TÜBİTAK) | PubMed | ||
| TDK-2022-4611 | Yıldız Technical University Scientific Research Projects | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31115493 | Mitochondrial electron transport chain, ROS generation and uncoupling (Review). | Int J Mol Med | 2019 | https://conductscience.org/library/papers/31115493 | PubMed |
| 2 | 27542250 | Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27542250 | PubMed |
| 3 | 27698868 | Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27698868 | PubMed |
| 4 | 27291334 | Deciphering the Molecular Signals of PINK1/Parkin Mitophagy. | Trends Cell Biol | 2016 | https://conductscience.org/library/papers/27291334 | PubMed |
| 5 | 26377470 | Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. | J Neurosci | 2015 | https://conductscience.org/library/papers/26377470 | PubMed |
| 6 | 35623793 | The Mitochondrial Pathway of Apoptosis: Part I: MOMP and Beyond. | Cold Spring Harb Perspect Biol | 2022 | https://conductscience.org/library/papers/35623793 | PubMed |
| 7 | 29039572 | Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway. | Oncol Rep | 2017 | https://conductscience.org/library/papers/29039572 | PubMed |
| 8 | 24606795 | Mitochondrial biogenesis: pharmacological approaches. | Curr Pharm Des | 2014 | https://conductscience.org/library/papers/24606795 | PubMed |
| 9 | 38809522 | Elevated PINK1/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin. | J Agric Food Chem | 2024 | https://conductscience.org/library/papers/38809522 | PubMed |
| 10 | 34132104 | Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. | Nanomedicine (Lond) | 2021 | https://conductscience.org/library/papers/34132104 | PubMed |
| 11 | 35288580 | Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress. | Nat Commun | 2022 | https://conductscience.org/library/papers/35288580 | PubMed |
| 12 | 23744360 | Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23744360 | PubMed |
| 13 | 15578914 | Targeting apoptosis pathways in cancer therapy. | Curr Cancer Drug Targets | 2004 | https://conductscience.org/library/papers/15578914 | PubMed |
| 14 | 32633007 | Thymoquinone (Tq) protects necroptosis induced by autophagy/mitophagy-dependent oxidative stress in human bronchial epithelial cells exposed to cigarette smoke extract (CSE). | J Food Biochem | 2020 | https://conductscience.org/library/papers/32633007 | PubMed |
| 15 | 24429632 | Mitochondrial form and function. | Nature | 2014 | https://conductscience.org/library/papers/24429632 | PubMed |
| 16 | 37582956 | The mitophagy pathway and its implications in human diseases. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37582956 | PubMed |
| 17 | 38046945 | Mitochondrial dynamics and metabolism across skin cells: implications for skin homeostasis and aging. | Front Physiol | 2023 | https://conductscience.org/library/papers/38046945 | PubMed |
| 18 | 23456297 | Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells. | Mol Cells | 2013 | https://conductscience.org/library/papers/23456297 | PubMed |
| 19 | 27252382 | TFEB at a glance. | J Cell Sci | 2016 | https://conductscience.org/library/papers/27252382 | PubMed |
| 20 | 33923474 | Thymoquinone, as a Novel Therapeutic Candidate of Cancers. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33923474 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| DNM1L | 10059 | PubTator's text mining | https://conductscience.org/library/genes/10059 | NCBI Gene |
| PINK1 | 65018 | PubTator's text mining | https://conductscience.org/library/genes/65018 | NCBI Gene |
| TFEB | 7942 | PubTator's text mining | https://conductscience.org/library/genes/7942 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41379258
GET https://conductscience.org/api/papers/v1/41379258/references?page=2